Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion type Assertion NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_head.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion description "[The frequency of TAP1, LMP2 and tapasin loss varied between 33% of primary adenocarcinomas, 40% of HIN to approximately 67% of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_provenance.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion evidence source_evidence_literature NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_provenance.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion SIO_000772 14750179 NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_provenance.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion wasDerivedFrom befree-20150227 NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_provenance.
- NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_assertion wasGeneratedBy ECO_0000203 NP722850.RAziAk5jprCbiGl6Y8Ic8WdZDT7wepN6FYva6l5RG0Ag8130_provenance.